XELA

-- -- --

Exela Technologies, Inc. announced that its Board of Directors has approved a 1-for-200 reverse stock split of the Company’s common stock, which will be effective at 5:00 p.m. Eastern Time on Friday, May 12, 2023.

From January 1, 2023 to March 31, 2023 Issuance of Common Stock from at the market offerings, net of offering costs

From January 1, 2022 to December 31, 2022 Common Stock exchanged for Series B Preferred Stock Issuance of Common Stock from at the market offerings, net of offering costs Common Stock issued for vested RSUs Agreed cancellation of Common Stock issued for Director's vested RSUs Common Stock repurchased and retired Issuance of Common Stock to Executive Chairman under certain subscription agreement Payment for fractional shares on Reverse Stock Split in 2022

From June 30, 2022 to September 30, 2022 Common Stock repurchased and retired Issuance of Common Stock from at the market offerings, net of offering costs Issuance of Common Stock to Executive Chairman under certain subscription agreement Cancellation of fractional Common Stock on Reverse Stock Split

Exela Technologies, Inc. announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company’s common stock, which will be effective at 5:00 p.m. Eastern Time on Monday, July 25, 2022. Immediately after the reverse split becomes effective, there will be approximately 64.8 million shares of common stock issued and outstanding.

From January 1, 2022 to March 31, 2022 Common Stock exchanged for Series B Preferred Stock Issuance of Common Stock from at the market offerings, net of offering costs Common Stock issued for vested RSUs

From January 1, 2021 to December 31, 2021 Preferred shares converted to Common Stock Payment for fractional shares on Reverse Stock Split Issuance of Common Stock to existing directors under subscription agreements Issuance of Common Stock from at the market offerings, net of offering costs Issuance of Common Stock from private placement

From June 30, 2021 to September 30, 2021 Issuance of Common Stock from at the market offerings, net of offering costs

From March 31, 2021 to June 30, 2021 Preferred shares converted to Common Stock Issuance of Common Stock from at the market offerings, net of offering costs

From January 1, 2021 To March 31, 2021 Preferred shares converted to Common Stock Payment for fractional shares on Reverse Stock Split Issuance of Common Stock

On January 25, 2021, Exela Technologies, Inc. (“Exela” or the “Company”) announced that it filed a Certificate of Amendment of the Company’s Second Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Amendment”), with the Secretary of State of Delaware, to effect a 1-for-3 reverse stock split (the “Reverse Split”) of the Company’s issued and outstanding shares of common stock, par value $0.0001 per share (the “Common Stock”), at 5:00 p.m. Eastern Time on that date. Beginning with the opening of trading on January 26, 2021, the Company’s Common Stock will trade on The Nasdaq Capital Market on a split-adjusted basis under a new CUSIP number 30162V409 and will continue to trade under the symbol “XELA.” As a result of the Reverse Split, the number of issued and outstanding shares of Common Stock will be adjusted from 147.7 million shares to approximately 49.2 million shares.

From March 31, 2020 to June 30, 2020 Adjustment to number of shares withheld in lieu of tax obligation of RSU holders in the year 2018

From January 1, 2020 to March 31, 2020 Shares returned in connection with the Appraisal Action as result of repayment of Margin Loan Preferred shares converted to common shares

From January 1, 2019 to December 31, 2019 RSUs vested Shares repurchased Preferred shares converted to common

from June 30, 2019 to September 30, 2019 RSUs vested Preferred shares converted to common

from March 31, 2019 to June 30,2019 RSU's vested Shares repurchased

from December 31, 2017 to December 31, 2018 Merger recapitalization Shares issued to acquire Novitex (refer to Note 3) Issuance\Conversion of Quinpario shares Sale of common shares at July 12, 2017 Issuance of Series A Preferred Stock Shares issued for advisory services and underwriting fees Conversion of Series A Preferred Stock to common shares Shares issued for HandsOn Global Management contract termination fee Treasury stock purchases

from December 31, 2017 to September 30, 2018 Stock options exercised Preferred shares converted to common Shares Repurchased

from December 31, 2017 to June 30, 2018 Preferred shares converted to common Shares Repurchased

from December 31, 2017 to March 31, 2018 Preferred shares converted to common

From January 1,2017 to December 31, 2017 Merger recapitalization Shares issued to acquire Novitex Issuance\Conversion of Quinpario shares Sale of common shares at July 12, 2017 Shares issued for advisory services and underwriting fees Conversion of Series A Preferred Stock to common shares Shares issued for HandsOn Global Management contract termination fee Treasury stock purchases Issuance of Series A Preferred Stock

From January 1,2017 to September 30, 2017 Merger recapitalization Shares issued to acquire Novitex Issuance\Conversion of Quinpario shares Sale of common shares at July 12, 2017 Shares issued for advisory services and underwriting fees Conversion of Series A Preferred Stock to common shares Shares issued for HandsOn Global Management contract termination fee Issuance of Series A Preferred Stock

The Business Combination Transaction was accounted for as a reverse merger for which SourceHOV was determined to be the accounting acquirer based on the following predominate factors: New SourceHOV will have the largest portion of voting rights in the newly formed entity, the largest minority shareholder of the combined entity is a current SourceHOV shareholder, the Board will have more individuals coming from SourceHOV than either the Company or Novitex, and SourceHOV is the largest entity by revenue and by assets.

from January 1, 2015 to March 9, 2015 Proceeds from the sale of 35,000,000 units Forfeiture of 1,312,500 shares following notice that Underwriters waived their right to exercise overallotment option Proceeds subject to possible redemption of 33,398,934 shares at redemption value

from July 15, 2014 to September 12, 2014 Sale of common stock issued to initial stockholder